文献速递肝病消化道肿瘤与早癌

糖尿病升高肝细胞癌风险,但丙型肝炎肝硬化患者除外

Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
PubMed 文献 · Am J Gastroenterol · 2016-08-16

研究纳入2006年1月至2011年12月在梅奥诊所罗切斯特院区接受重复影像学评估的739例肝硬化患者,其中253例(34%)患糖尿病,中位随访38个月后69例(9%)发生肝细胞癌。在无丙型肝炎病毒(HCV)感染的患者中,糖尿病与肝细胞癌风险显著相关(HR=2.1,95%CI=1.1-4.1),而在HCV感染者中无关联(HR=0.8,95%CI=0.4-1.8)。结论认为糖尿病增加非HCV肝硬化患者的肝细胞癌风险,而在本已高风险的HCV肝硬化患者中糖尿病可能不再进一步增加风险。

要点

  • 在无HCV感染的肝硬化患者中,糖尿病与肝细胞癌风险显著相关(HR=2.1,95%CI=1.1-4.1)。
  • 在HCV肝硬化患者中,糖尿病与肝细胞癌风险无关联(HR=0.8,95%CI=0.4-1.8)。
  • HCV与糖尿病的交互作用经协变量调整后仍显著(非HCV的HR=1.9,95%CI=0.9-3.7;HCV的HR=0.6,95%CI=0.2-1.3)。

核心结论

  • 糖尿病增加非HCV肝硬化患者的肝细胞癌风险;在已具有很高风险的HCV肝硬化患者中,糖尿病可能不会进一步增加风险。

研究设计与样本

  • 纳入2006年1月至2011年12月在梅奥诊所罗切斯特院区接受重复影像学评估(超声、计算机断层扫描或磁共振成像)的所有肝硬化患者,共739例符合标准,其中253例(34%)患糖尿病,采用Cox比例风险回归分析糖尿病对肝细胞癌风险的影响。

主要发现

  • 中位随访38个月后,69例(9%)患者发生肝细胞癌。
  • 在无HCV感染的患者中,糖尿病与发生肝细胞癌的风险显著相关(HR=2.1,95%CI=1.1-4.1);在HCV感染患者中无关联(HR=0.8,95%CI=0.4-1.8)。
  • 经协变量调整后,HCV与糖尿病的交互作用仍显著(非HCV的HR=1.9,95%CI=0.9-3.7;HCV的HR=0.6,95%CI=0.2-1.3)。
  • 糖尿病与肝细胞癌缺乏关联这一结果在HALT-C试验纳入的410例HCV肝硬化患者中进行了外部验证。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: As most hepatocellular carcinoma (HCC) patients have cirrhosis, the association between diabetes and HCC may be confounded by the fact that diabetes is common in patients with cirrhosis. The aim of this study is to investigate whether diabetes increases the risk of HCC in patients with cirrhosis and whether the etiology of liver disease modifies the association between diabetes and HCC. METHODS: All liver cirrhosis patients who had repeated radiographic evaluation of the liver (that is, ultrasound, computed tomography, or magnetic resonance image) at Mayo Clinic Rochester between January 2006 and December 2011 were included. The Cox proportional hazard regression analysis was used to investigate the effect of diabetes on the risk of HCC. RESULTS: A total of 739 patients met the eligibility criteria, of whom 253 (34%) had diabetes. After a median follow-up of 38 months, 69 (9%) patients developed HCC. In patients without hepatitis C virus (HCV) infection, diabetes was significantly associated with the risk of developing HCC (hazard ratio (HR)=2.1, 95% confidence interval (CI)=1.1-4.1), whereas in patients with HCV, there was no association (HR=0.8, 95% CI=0.4-1.8). When adjusted for covariates, the interaction between HCV and diabetes remained significant (HR for non-HCV=1.9, 95% CI=0.9-3.7; HR for HCV=0.6, 95% CI=0.2-1.3). Lack of association between diabetes and HCC was externally validated in 410 patients with HCV cirrhosis enrolled in the HALT-C trial. CONCLUSIONS: Diabetes increases the risk of HCC in patients with non-HCV cirrhosis. In HCV cirrhosis patients who already have very high risk, diabetes may not increase the risk any further.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Yang JD, Mohamed HA, Cvinar JL, et al. Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis. Am J Gastroenterol. 2016. PMID: 27527741. doi:10.1038/ajg.2016.330

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。